These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Di Marco F; Santus P; Scichilone N; Solidoro P; Contoli M; Braido F; Corsico AG Respir Med; 2017 Apr; 125():49-56. PubMed ID: 28340862 [TBL] [Abstract][Full Text] [Related]
7. Comparative Effectiveness of Long-Acting Beta Samp JC; Joo MJ; Schumock GT; Calip GS; Pickard AS; Lee TA Pharmacotherapy; 2017 Apr; 37(4):447-455. PubMed ID: 28226405 [TBL] [Abstract][Full Text] [Related]
8. Discovery of Clinical Candidate CHF-6366: A Novel Super-soft Dual Pharmacology Muscarinic Antagonist and β Carzaniga L; Linney ID; Rizzi A; Delcanale M; Schmidt W; Knight CK; Pastore F; Miglietta D; Carnini C; Cesari N; Riccardi B; Mileo V; Venturi L; Moretti E; Blackaby WP; Patacchini R; Accetta A; Biagetti M; Bassani F; Tondelli M; Murgo A; Battipaglia L; Villetti G; Puccini P; Catinella S; Civelli M; Rancati F J Med Chem; 2022 Aug; 65(15):10233-10250. PubMed ID: 35901125 [TBL] [Abstract][Full Text] [Related]
9. Discovery of muscarinic acetylcholine receptor antagonist and beta 2 adrenoceptor agonist (MABA) dual pharmacology molecules. Hughes AD; Chin KH; Dunham SL; Jasper JR; King KE; Lee TW; Mammen M; Martin J; Steinfeld T Bioorg Med Chem Lett; 2011 Mar; 21(5):1354-8. PubMed ID: 21310610 [TBL] [Abstract][Full Text] [Related]
10. Molecular hybridization yields triazole bronchodilators for the treatment of COPD. Jones LH; Burrows J; Feeder N; Glossop P; James K; Jones RM; Kenyon AS; Patel S; Roberts DF; Selby MD; Strang RS; Stuart EF; Trevethick MA; Watson J; Wright KN; Clarke N Bioorg Med Chem Lett; 2015 Nov; 25(22):5121-6. PubMed ID: 26471092 [TBL] [Abstract][Full Text] [Related]
11. Bronchodilating drugs for chronic obstructive pulmonary disease: current status and future trends. Montuschi P; Ciabattoni G J Med Chem; 2015 May; 58(10):4131-64. PubMed ID: 25587755 [TBL] [Abstract][Full Text] [Related]
12. Inhaled muscarinic acetylcholine receptor antagonists for treatment of COPD. Montuschi P; Macagno F; Valente S; Fuso L Curr Med Chem; 2013; 20(12):1464-76. PubMed ID: 22963553 [TBL] [Abstract][Full Text] [Related]
13. Pharmacological preclinical characterization of LAS190792, a novel inhaled bifunctional muscarinic receptor antagonist /β Aparici M; Carcasona C; Ramos I; Montero JL; Ortiz JL; Cortijo J; Puig C; Vilella D; Doe C; Gavaldà A; Miralpeix M Pulm Pharmacol Ther; 2017 Oct; 46():1-10. PubMed ID: 28729041 [TBL] [Abstract][Full Text] [Related]
14. Role of Long-Acting Muscarinic Antagonist/Long-Acting β Petite SE Ann Pharmacother; 2017 Aug; 51(8):696-705. PubMed ID: 28410560 [TBL] [Abstract][Full Text] [Related]
15. Pharmacological Profile of AZD8871 (LAS191351), a Novel Inhaled Dual M Aparici M; Carcasona C; Ramos I; Montero JL; Otal R; Ortiz JL; Cortijo J; Puig C; Vilella D; De Alba J; Doe C; Gavaldà A; Miralpeix M J Pharmacol Exp Ther; 2019 Jul; 370(1):127-136. PubMed ID: 31085697 [TBL] [Abstract][Full Text] [Related]
16. Dual-pharmacology muscarinic antagonist and β₂ agonist molecules for the treatment of chronic obstructive pulmonary disease. Hughes AD; Jones LH Future Med Chem; 2011 Oct; 3(13):1585-605. PubMed ID: 21942250 [TBL] [Abstract][Full Text] [Related]
17. Navafenterol (AZD8871) in patients with COPD: a randomized, double-blind, phase I study evaluating safety and pharmacodynamics of single doses of this novel, inhaled, long-acting, dual-pharmacology bronchodilator. Singh D; Balaguer V; Astbury C; Wählby-Hamrén U; Jimenez E; Seoane B; Villarroel C; Lei A; Aggarwal A; Psallidas I Respir Res; 2020 Sep; 21(Suppl 1):102. PubMed ID: 32907566 [TBL] [Abstract][Full Text] [Related]
18. Long acting muscarinic antagonists for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs. Mastrodicasa MA; Droege CA; Mulhall AM; Ernst NE; Panos RJ; Zafar MA Expert Opin Investig Drugs; 2017 Feb; 26(2):161-174. PubMed ID: 28004591 [TBL] [Abstract][Full Text] [Related]
19. The burden of chronic obstructive pulmonary disease associated with maintenance monotherapy in the UK. Edwards SC; Fairbrother SE; Scowcroft A; Chiu G; Ternouth A; Lipworth BJ Int J Chron Obstruct Pulmon Dis; 2016; 11():2851-2858. PubMed ID: 27920512 [TBL] [Abstract][Full Text] [Related]
20. Inhaled glycopyrrolate for the treatment of chronic obstructive pulmonary disease. Tashkin DP; Gross NJ Int J Chron Obstruct Pulmon Dis; 2018; 13():1873-1888. PubMed ID: 29928118 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]